Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics AG shares valued at $1,013,564 were sold by Kulkarni Samarth on Feb 19 ’25. At $55.20 per share, Kulkarni Samarth sold 18,360 shares. The insider’s holdings dropped to 171,613 shares worth approximately $7.49 million following the completion of this transaction.
Also, Kulkarni Samarth sold 11,640 shares, netting a total of over 640,782 in proceeds. Following the sale of shares at $55.05 each, the insider now holds 196,901 shares.
Before that, Kulkarni Samarth had sold 6,928 shares from its account. In a trade valued at $365,798, the Chief Executive Officer traded CRISPR Therapeutics AG shares for $52.80 each. Upon closing the transaction, the insider’s holdings decreased to 6,928 shares, worth approximately $8.29 million.
As published in a research note from Evercore ISI on February 14, 2025, CRISPR Therapeutics AG [CRSP] has been rated up from an In-line to an Outperform and the price target has been revised to $99 from $60. Analysts at TD Cowen upgraded the stock from ‘”a Sell”‘ to ‘”a Hold”‘ outlook in a report released in mid February. As of February 03, 2025, H.C. Wainwright has initiated its “Buy” rating for CRSP. Earlier on August 06, 2024, Needham resumed its rating. Their recommendation was “a Buy” for CRSP stock.
Analyzing CRSP Stock Performance
During the last five days, there has been a drop of approximately -13.50%. Over the course of the year, CRISPR Therapeutics AG shares have jumped approximately 10.82%. Shares of the company reached a 52-week high of $55.88 on 02/19/25 and a 52-week low of $36.52 on 01/13/25. A 50-day SMA is recorded $42.47, while a 200-day SMA reached $49.25. Nevertheless, trading volume fell to 1.47 million shares from 1.24 million shares the previous day.
Support And Resistance Levels for CRISPR Therapeutics AG (CRSP)
According to the 24-hour chart, there is a support level at 42.49, which, if violated, would cause prices to drop to 41.37. In the upper region, resistance lies at 45.76. The next price resistance is at 47.91. RSI (Relative Strength Index) is 47.68 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.39, which suggests the price will decrease in the coming days. Percent R is at 69.66%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
